| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/20/2002 | CN1340350A Chewing medicine for treating facial paralysis and its preparing process |
| 03/20/2002 | CN1340344A Prescription of 'strong heart first-aid dropping pill' and its preparing process |
| 03/20/2002 | CN1340342A Application of piperidine nitroxide in preventing and treating oxidized injury of skin |
| 03/20/2002 | CN1340341A Thiaminogen injection and its preparing process |
| 03/20/2002 | CN1340310A Solid preparation with multi-core texture |
| 03/20/2002 | CN1081194C Potassium alginate process for preparing potassium alginate and its use |
| 03/20/2002 | CN1081190C Antineoplastic and insecticidal total annonacin and preparing process thereof |
| 03/20/2002 | CN1081189C Azole alcohol derivatives, prepn method and pharmaceutical use thereof |
| 03/20/2002 | CN1081187C Inhibitors of prenuyl transferases |
| 03/20/2002 | CN1081184C Fluorinated vitamin D3 analogs |
| 03/20/2002 | CN1081066C Meidine for curing burn and scald and its preparation method |
| 03/20/2002 | CN1081062C Brain nutritious oral liquor and its preparation |
| 03/20/2002 | CN1081060C Ointment for curing skin ulcer |
| 03/20/2002 | CN1081052C Fast-acting piles-treating Chinese medicine preparation |
| 03/20/2002 | CN1081049C Medicine for rheumatic arthritis |
| 03/20/2002 | CN1081038C Beta-glucan products and extraction process from cereals thereof |
| 03/20/2002 | CN1081037C Azithromycin suppository and ointment |
| 03/20/2002 | CN1081036C Anticarcinogen |
| 03/20/2002 | CN1081035C Antimalarial compound naphtholquine |
| 03/20/2002 | CN1081034C Medicine of diguanidino-prine-hydride compounds for giving up drug-taking |
| 03/20/2002 | CN1081033C Partial slow-released glutathione inhibitor |
| 03/20/2002 | CN1081032C Medicinal preparation containing saccharin zinc |
| 03/20/2002 | CN1081031C Calcium tablet |
| 03/20/2002 | CN1081030C External preparation containing tranilast and process for producing the same |
| 03/20/2002 | CN1081029C Sustained-release metal valproate tablets |
| 03/20/2002 | CN1081028C Patch for external use |
| 03/19/2002 | US6359182 C-nitroso compounds and use thereof |
| 03/19/2002 | US6359181 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 03/19/2002 | US6359169 GABA and L-glutamic acid analogs for antiseizure treatment |
| 03/19/2002 | US6359167 Stable NO-delivering compounds |
| 03/19/2002 | US6359158 A 16-hydroxyeicosatetraenoic acid antagonist; antiinflammatory agents |
| 03/19/2002 | US6359156 Controlling diseases in cereal plants |
| 03/19/2002 | US6359154 Exceptional utility as antitumor agents; bioavailability and nontoxic; oral administration; e.g., 10-hydroxy-10-deacetyl baccatin iii; anticarcinogenic agents |
| 03/19/2002 | US6359146 Resolution of enantiomorph mixture |
| 03/19/2002 | US6359145 Imidazole compounds |
| 03/19/2002 | US6359138 4-hydroxy-piperidine derivatives |
| 03/19/2002 | US6359137 Antibiotic |
| 03/19/2002 | US6359136 Antithrombotic agents |
| 03/19/2002 | US6359135 Compounds having activity as inhibitors of cytochrome P450RAI |
| 03/19/2002 | US6359130 Bridged indenopyrrolocarbazoles |
| 03/19/2002 | US6359124 Nucleotide sequences for use in the diagnosis, detection and treatment of arrhythmia, long q-t syndrome and cancers |
| 03/19/2002 | US6359017 Dietary compositions and methods |
| 03/19/2002 | US6359016 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 03/19/2002 | US6359015 Method for antagonizing inhibition effects of alcohol on cell adhesion |
| 03/19/2002 | US6359014 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 03/19/2002 | US6359013 Styryl sulfone anticancer agents |
| 03/19/2002 | US6359012 Method for making 24(S)-hydroxyvitamin D2 |
| 03/19/2002 | US6359011 Denaturants for sympathomimetic amine salts |
| 03/19/2002 | US6359010 Methods of treating anxiety and mood disorders with oleamide |
| 03/19/2002 | US6359007 Vascular insufficiency |
| 03/19/2002 | US6359005 Method for the treatment of mania and bipolar disorder |
| 03/19/2002 | US6359004 Manipulating nitrosative stress to upregulate nitrosative stress defenses |
| 03/19/2002 | US6359003 Fumaric acid alkyl esters for suppressing host versus graft reaction |
| 03/19/2002 | US6359002 Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| 03/19/2002 | US6359001 Use of α-methyl-p-tyrosine to inhibit melanin production in iris melanocytes |
| 03/19/2002 | US6359000 Pine root (deutero mycetes) fungal metabolite, naturally occurring terpenoid, steroid, and polyketide compounds, |
| 03/19/2002 | US6358999 Orally administering zinc tranexamate for diabetis therapy |
| 03/19/2002 | US6358998 Body fat-reducing agent comprising dioxabicyclo[3.3.0] octane derivative as active ingredient |
| 03/19/2002 | US6358997 Treating hypercholesteremia and/or hyperlipidemia by the administration of natural tocotrienols and natural tocopherols. |
| 03/19/2002 | US6358994 2-acylaminopropanamines as tachykinin receptor antagonists |
| 03/19/2002 | US6358992 Method of inhibiting neoplastic cells with indole derivatives |
| 03/19/2002 | US6358991 By administering indole compounds such as 1-(4-(2-azepan-1yl-ethoxy)-benzyl)-2-(4-hydroxy-phenyl)-3-methyl-1h-indol-5 -ol; epilepsy, asthma, eating disorders, obesity, neurodegenertive conditions, schizophrenia |
| 03/19/2002 | US6358990 Method for treating Alzheimer's disease |
| 03/19/2002 | US6358989 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/19/2002 | US6358987 For therapy and prophylaxis of rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, gingivitis, corneal epidermal or gastric ulceration, and tumour metastasis, invasion and growth |
| 03/19/2002 | US6358985 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358984 For therapy of hypertension and/or diseases such as heart and renal diseases |
| 03/19/2002 | US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 03/19/2002 | US6358982 Heterocyclyl sulphonamide derivatives |
| 03/19/2002 | US6358980 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 03/19/2002 | US6358978 Substituted benzimidazoles |
| 03/19/2002 | US6358977 Therapy of neurodevelopmental disorder such as autistic spectrum disorders/autistic continuum disorders, pervasive developmental disorders, attention deficit hyperactivity disorder, etc., by administering piperidinemethanol compound |
| 03/19/2002 | US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration |
| 03/19/2002 | US6358975 Method of using selective parp inhibitors to prevent or treat neurotoxicity |
| 03/19/2002 | US6358974 Used as as modulators of dopamine d.sub.3 receptors, in therapy as antipsychotic agents |
| 03/19/2002 | US6358973 For therapy of allergic or inflammatory disease |
| 03/19/2002 | US6358972 5-HT1F agonists |
| 03/19/2002 | US6358970 Integrin receptor antagonists |
| 03/19/2002 | US6358969 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 03/19/2002 | US6358968 N-substituted urea inhibitors of farnesyl-protein transferase |
| 03/19/2002 | US6358967 Ergoline amine derivatives with blood pressure lowering effect |
| 03/19/2002 | US6358966 Using 1-(4-(1-(4-fluorophenyl)-1h-indole-3-yl)-1-butyl spiro(isobenzofuran-1(3h,4-piperidine) |
| 03/19/2002 | US6358965 Use of benzoylalkyl-1,2,3,6-tetrahydropyridines |
| 03/19/2002 | US6358964 Adenosine, A3 receptor modulators |
| 03/19/2002 | US6358963 For therapy of viral infections |
| 03/19/2002 | US6358962 6,7-Dimethoxyquinazolines and therapeutic use thereof |
| 03/19/2002 | US6358961 Farnesyltransferase inhibiting quinazolinones |
| 03/19/2002 | US6358958 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/19/2002 | US6358957 Cancer therapy |
| 03/19/2002 | US6358956 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358954 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 03/19/2002 | US6358953 Administering pterin metal complex as anticarcinogenic agents and viricides |
| 03/19/2002 | US6358952 Combination of benzoquinazoline antifolates and protecting agents |
| 03/19/2002 | US6358951 Administering pyrazolo(4,3-c)pyridine derivative to treat obesity, congestive heart failure, osteoporosis, aging, bone and muscular disorders |
| 03/19/2002 | US6358950 Administering (1,5-a)-pyrazolo-1,3,5-triazine derivatives as anxiolytic agents and antidepressants; corticotropin releasing factor antagonists; cardiovascular, autoimmune, nervous system, eating, and psychological disorders |
| 03/19/2002 | US6358948 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 03/19/2002 | US6358947 Tetracyclic progesterone receptor modulator compounds and methods |
| 03/19/2002 | US6358946 C-6 ring-substituted pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358944 Methods and compositions for treating generalized anxiety disorder |